An overview of novel therapies for Parkinson's disease

被引：4

作者：

Fahn, S ^{[1
]}

机构：

[1] PRESBYTERIAN HOSP, NEUROL INST, NEW YORK, NY 10032 USA

来源：

EXPERIMENTAL NEUROLOGY | 1997年 / 144卷 / 01期

关键词：

D O I：

10.1006/exnr.1996.6382

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

[No abstract available]

引用

收藏

页码：21 / 23

页数：3

相关论文

共 43 条

[41] THE EFFECT OF DEPRENYL (SELEGILINE) ON THE NATURAL-HISTORY OF PARKINSONS-DISEASE [J].

TETRUD, JW ;

LANGSTON, JW .

SCIENCE, 1989, 245 (4917) :519-522

[42] SELECTIVE MAO-A AND MAO-B INHIBITORS, RADICAL SCAVENGERS AND NITRIC-OXIDE SYNTHASE INHIBITORS IN PARKINSONS-DISEASE [J].

YOUDIM, MBH ;

LAVIE, L .

LIFE SCIENCES, 1994, 55 (25-26) :2077-2082

[43] BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons [J].

Yurek, DM ;

Lu, W ;

Hipkens, S ;

Wiegand, SJ .

EXPERIMENTAL NEUROLOGY, 1996, 137 (01) :105-118

← 1 2 3 4 5 →